Cullinan Oncology (CGEM) Earnings (2020 - 2026)
Cullinan Oncology (CGEM) earnings from Mar 31, 2020 to Mar 31, 2026. The TTM Cullinan Oncology (CGEM) earnings is -$221M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Cullinan Oncology (CGEM) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +23.67% |
| 5 Years TTM | +36.35% |
| All Time TTM | +36.36% |
Annual Earnings change of Cullinan Oncology (CGEM)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$50M | -77.41% |
| 2025 | -$220M | +31.37% |
| 2024 | -$167M | +9.28% |
| 2023 | -$153M | -237.72% |
| 2022 | $111M | -269.61% |
| 2021 | -$66M | +26.58% |
| 2020 | -$52M | N/A |
Comparison Cullinan Oncology (CGEM) five years earnings CAGR with competitors
Cullinan Oncology (CGEM) five years earnings CAGR is 36.35%.